Literature DB >> 23936588

Lymphoplasmacyte-rich meningioma: our experience with 19 cases and a systematic literature review.

Hong-Da Zhu1, Qing Xie, Ye Gong, Ying Mao, Ping Zhong, Feng-Ping Hang, Hong Chen, Ming-Zhe Zheng, Hai-Liang Tang, Dai-Jun Wang, Xian-Cheng Chen, Liang-Fu Zhou.   

Abstract

OBJECTIVE: To investigate the clinicopathological characteristics, prognosis, pathology, and differential diagnosis of LPM by analyzing our experience and reviewed relevant literature. We also postulated the necessity of postoperative adjuvant therapy.
METHODS: 19 patients with LPM underwent surgical treatment from 2007 through 2010 in our department. The clinical charts of the patients, including surgical, histological, and follow-up records, as well as imaging studies, were analyzed retrospectively. Other 43 cases searched from the literature were also included, so that 62 LPM cases were summarized and reviewed together.
RESULTS: The summarized 62 patients comprised 30 males and 31 females aged 9 years to 79 years (40.7±18.3 years). The most common locations were convexity, skull base, para-sagittal and cervical canal. Multiple or diffuse lesions were found in 8 cases. There were 13 patients had peripheral blood abnormalities (21%). One-third of the cases had moderate to severe peritumoral brain edema. Thirty-eight patients had total resection, 12 patients not specified while 12 received subtotal resection or only biopsy. MIB-1 was available in 24 cases and a third of them were higher than 3%. Follow-up more than 3 year was only completed in 19/62 cases. Seven cases suffered recurrence and two of them died after 2 years of operation.
CONCLUSION: LPM is a very rare benign variant of intracranial meningioma. Both lesions and hematological abnormalities have a predilection for younger individuals. Preoperative diagnosis of this subtype of meningioma is still difficult. Surgical resection is the primary treatment option, and supportive care for those not totally removed is very important, because the recurrence rate for this subtype is rather low. However, the massive infiltration of lymphocytes and plasma cells in LPMs are still controversial and the long-term follow-ups are needed. Radiotherapy is not recommended, and hormonal or immune-inhibitor therapy might be helpful.

Entities:  

Keywords:  Diagnosis; differential diagnosis; edema; lymphoplasmacyte-rich meningioma; prognosis

Year:  2013        PMID: 23936588      PMCID: PMC3731181     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  44 in total

Review 1.  Lymphoplasmacyte rich meningioma. A case report and review of the literature.

Authors:  M C Bruno; C Ginguené; M Santangelo; K Panagiotopoulos; G A Piscopo; F Tortora; A Elefante; M L De Caro; A Cerillo
Journal:  J Neurosurg Sci       Date:  2004-09       Impact factor: 2.279

2.  Lymphoplasmacyte-rich meningioma at the foramen magnum.

Authors:  S Avninder; V Gupta; K C Sharma
Journal:  Br J Neurosurg       Date:  2008-10       Impact factor: 1.596

3.  Inflammatory pseudotumors of the central nervous system.

Authors:  Philip C W Lui; Yuen Shan Fan; Steve S Wong; Alice N H Chan; George Wong; Tony K F Chau; Gary M K Tse; Yue Cheng; Wai S Poon; Ho Keung Ng
Journal:  Hum Pathol       Date:  2009-08-05       Impact factor: 3.466

4.  October 2000: a 47 year old man with long-standing progressive tetraparesis.

Authors:  J E Pittella; C C da Costa; A V Giannetti; F O Perpétuo
Journal:  Brain Pathol       Date:  2001-04       Impact factor: 6.508

5.  Plasma cell granulomas of the lung.

Authors:  M Bahadori; A A Liebow
Journal:  Cancer       Date:  1973-01       Impact factor: 6.860

6.  Inflammatory myofibroblastic tumor of the central nervous system: clinicopathologic analysis of 10 cases.

Authors:  Yoon Kyung Jeon; Kee-Hyun Chang; Yeon-Lim Suh; Hee Won Jung; Sung-Hye Park
Journal:  J Neuropathol Exp Neurol       Date:  2005-03       Impact factor: 3.685

7.  Cystic lymphoplasmacyte-rich meningioma--case report.

Authors:  S Katayama; T Fukuhara; T Wani; S Namba; I Yamadori
Journal:  Neurol Med Chir (Tokyo)       Date:  1997-03       Impact factor: 1.742

8.  Meningioma with conspicuous plasma cell components. A histopathological and immunohistochemical study.

Authors:  F C Stam; H A van Alphen; D M Boorsma
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

9.  Lymphoplasmacyte-rich meningioma in a child. Case report.

Authors:  H Loiseau; J M Pedespan; A Vital; C Marchal; C Vital; F Cohadon
Journal:  J Neurosurg       Date:  1995-12       Impact factor: 5.115

10.  Lymphoplasmacyte-rich meningioma mimicking idiopathic hypertrophic pachymeningitis.

Authors:  Parima Hirunwiwatkul; Jonathan D Trobe; Mila Blaivas
Journal:  J Neuroophthalmol       Date:  2007-06       Impact factor: 3.042

View more
  11 in total

Review 1.  Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.

Authors:  Shona Hendry; Roberto Salgado; Thomas Gevaert; Prudence A Russell; Tom John; Bibhusal Thapa; Michael Christie; Koen van de Vijver; M V Estrada; Paula I Gonzalez-Ericsson; Melinda Sanders; Benjamin Solomon; Cinzia Solinas; Gert G G M Van den Eynden; Yves Allory; Matthias Preusser; Johannes Hainfellner; Giancarlo Pruneri; Andrea Vingiani; Sandra Demaria; Fraser Symmans; Paolo Nuciforo; Laura Comerma; E A Thompson; Sunil Lakhani; Seong-Rim Kim; Stuart Schnitt; Cecile Colpaert; Christos Sotiriou; Stefan J Scherer; Michail Ignatiadis; Sunil Badve; Robert H Pierce; Giuseppe Viale; Nicolas Sirtaine; Frederique Penault-Llorca; Tomohagu Sugie; Susan Fineberg; Soonmyung Paik; Ashok Srinivasan; Andrea Richardson; Yihong Wang; Ewa Chmielik; Jane Brock; Douglas B Johnson; Justin Balko; Stephan Wienert; Veerle Bossuyt; Stefan Michiels; Nils Ternes; Nicole Burchardi; Stephen J Luen; Peter Savas; Frederick Klauschen; Peter H Watson; Brad H Nelson; Carmen Criscitiello; Sandra O'Toole; Denis Larsimont; Roland de Wind; Giuseppe Curigliano; Fabrice André; Magali Lacroix-Triki; Mark van de Vijver; Federico Rojo; Giuseppe Floris; Shahinaz Bedri; Joseph Sparano; David Rimm; Torsten Nielsen; Zuzana Kos; Stephen Hewitt; Baljit Singh; Gelareh Farshid; Sibylle Loibl; Kimberly H Allison; Nadine Tung; Sylvia Adams; Karen Willard-Gallo; Hugo M Horlings; Leena Gandhi; Andre Moreira; Fred Hirsch; Maria V Dieci; Maria Urbanowicz; Iva Brcic; Konstanty Korski; Fabien Gaire; Hartmut Koeppen; Amy Lo; Jennifer Giltnane; Marlon C Rebelatto; Keith E Steele; Jiping Zha; Kenneth Emancipator; Jonathan W Juco; Carsten Denkert; Jorge Reis-Filho; Sherene Loi; Stephen B Fox
Journal:  Adv Anat Pathol       Date:  2017-11       Impact factor: 3.875

2.  Large dural-based mass with bony hyperostosis in a 16-year-old male: IgG4-related disease mimicking lymphoplasmacyte-rich meningioma.

Authors:  A Nambirajan; M Chand Sharma; K Garg; S Sriram; M Thej Boorgula; V Suri
Journal:  Childs Nerv Syst       Date:  2019-05-09       Impact factor: 1.475

3.  Minimal invasive trans-eyelid approach to anterior and middle skull base meningioma: a preliminary study of Shanghai Huashan hospital.

Authors:  Qing Xie; Dai-Jun Wang; Li Sun; Ying Mao; Ping Zhong; Ming-Zhe Zheng; Hai-Liang Tang; Hong-Da Zhu; Xian-Cheng Chen; Liang-Fu Zhou; Ye Gong
Journal:  Int J Clin Exp Med       Date:  2014-11-15

4.  Immunohistochemical and genetic markers to distinguish hemangiopericytoma and meningioma.

Authors:  Penglai Zhao; Tongming Zhu; Qisheng Tang; Hongyi Liu; Jianhong Zhu; Wenbin Zhang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

5.  Prognostic significance of preoperative neutrophilia on recurrence-free survival in meningioma.

Authors:  Shirin Karimi; Manav V Vyas; Lior Gonen; Raha Tabasinejad; Quinn T Ostrom; Jill Barnholtz-Sloan; Suganth Suppiah; Gelareh Zadeh; Kenneth Aldape
Journal:  Neuro Oncol       Date:  2017-10-19       Impact factor: 12.300

Review 6.  Pathology and molecular genetics of meningioma: recent advances.

Authors:  Makoto Shibuya
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-12-20       Impact factor: 1.742

7.  A rare cystic lymphoplasmacyte-rich meningioma: A case report and review of the literature.

Authors:  Muhammad Firdaus; Arwinder S Gill; Rini Andriani; Dian Cahyanti; Maria R Yunti; Ahmad Faried
Journal:  Surg Neurol Int       Date:  2020-11-18

8.  Lymphoplasmacyte-rich meningioma: A rare histologic variant of benign meningioma with atypical bone invasion.

Authors:  Gonçalo Borges de Almeida; Gonçalo Januário
Journal:  Radiol Case Rep       Date:  2022-01-15

9.  A case of Lymphoplasmacyte-rich meningioma mimicking pachymeningitis.

Authors:  Yue Zhang; Xiang Zhang; Abhijeet Kumar Bhekharee; Zunguo Du; Shuguang Chu
Journal:  BMC Neurol       Date:  2022-07-29       Impact factor: 2.903

10.  Lymphoplasmacyte-rich meningioma with hematologic signs and PD-L1 over-expression.

Authors:  Gabriele Gaggero; Michela Campora; Davide Taietti; Giannamaria Cerruti; Enrico Lo Bue; Monica Truffelli; Marco Ceraudo; Pietro Fiaschi
Journal:  Autops Case Rep       Date:  2022-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.